Search

Your search keyword '"Colantuono, Stefania"' showing total 153 results

Search Constraints

Start Over You searched for: Author "Colantuono, Stefania" Remove constraint Author: "Colantuono, Stefania"
153 results on '"Colantuono, Stefania"'

Search Results

1. Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study

5. Severe asthma: One disease and multiple definitions

6. Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study

7. Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life

8. Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar)

11. Dual stimulation by autoantigen and CpG fosters the proliferation of exhausted rheumatoid factor-specific CD21low B cells in hepatitis C virus-cured mixed cryoglobulinemia.

12. Immunoglobulin Free Light Chains in Severe Asthma Patient: could they be a new biomarker?

13. Clinical research coordinators: Key components of an efficient clinical trial unit

14. Dual stimulation by autoantigen and CpG fosters the proliferation of exhausted rheumatoid factor-specific CD21low B cells in hepatitis C virus-cured mixed cryoglobulinemia

17. Clinical research coordinators: Key components of an efficient clinical trial unit

19. Different aspects of severe asthma in real life: Role of Staphylococcus aureus enterotoxins and correlation to comorbidities and disease severity

20. Different aspects of severe asthma in real life: Role of Staphylococcus aureus enterotoxins and correlation to comorbidities and disease severity.

22. Autoimmune hepatitis with eosinophilic infiltration responsive to anti-interleukin-5 receptor treatment: a case report and literature review.

23. Severe asthma: One disease and multiple definitions

26. β-Lactam Allergy and Cross-Reactivity: A Clinician’s Guide to Selecting an Alternative Antibiotic

28. Cryoglobulins: putative effectors of adaptive immune response

29. Real-life survey on severe asthma patients during COVID-19 lockdown in Italy

30. Mutational and immunogenetic landscape of HCV ‐associated B‐cell lymphoproliferative disorders

31. Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression

32. Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life

34. Clinico‐immunological outcomes of HCV‐cured cryoglobulinemia: Lower relapse rate with interferon‐based than interferon‐free therapy

37. Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar)

40. Prospective Italian real‐world study of mepolizumab in severe eosinophilic asthma validates retrospective outcome reports.

41. Immunobiology of essential mixed cryoglobulinemia

42. CD21low B cells are predictive markers of new digital ulcers in systemic sclerosis.

43. Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia.

44. Long‐lasting persistence of large B‐cell clones in hepatitis C virus‐cured patients with complete response of mixed cryoglobulinaemia vasculitis

46. Clinico‐immunological outcomes of HCV‐cured cryoglobulinemia: Lower relapse rate with interferon‐based than interferon‐free therapy.

50. Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia

Catalog

Books, media, physical & digital resources